FDA product code QKF: Immunocytochemistry Assay, P16/Ki-67

QKF is the FDA product code for immunocytochemistry assay, p16/ki-67. It is a Class III device, regulated under 21 CFR 864.1860 and reviewed by the Pathology panel. Devices under QKF reach the market by PMA; FDA lists no cleared 510(k)s for it. 1 PMA application cites this product code.

Definition

The p16 and Ki-67 antibody cocktail is a qualitative immunocytochemical assay intended for the simultaneous detection of the p16INK4a (E6H4) and Ki-67 (274-11AC3V1) proteins in cervical specimens collected by a clinician.

Classification

FieldValue
Device nameImmunocytochemistry Assay, P16/Ki-67
Device classClass III
Regulation21 CFR 864.1860
Review panelPA — Pathology
Medical specialtyHematology
Premarket routePMA

Recalls for QKF devices

FDA recall records list no recalls for product code QKF.

Frequently asked questions

What is FDA product code QKF?

QKF is the FDA product code for immunocytochemistry assay, p16/ki-67. It is a Class III device, regulated under 21 CFR 864.1860 and reviewed by the Pathology panel.

What device class is QKF?

Class III, regulation 21 CFR 864.1860. Typical premarket route: PMA.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Pathology product codes · FDA product code lookup · 510(k) database search · 510(k) review times